Corona Virus Net is the web resource for anyone interested in Coronaviruses. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (COVID-19) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and humans. Common signs of infection include respiratory symptoms, fever, cough, and shortness of breath. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing. Also avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing.

A pneumonia of unknown cause detected in Wuhan, China was first reported to the WHO on 31 December 2019. The outbreak of COVID-19 was declared a Public Health Emergency of International Concern on 30 January 2020 by the WHO. As of March 11th, the WHO declared the rapidly spreading coronavirus outbreak a pandemic, acknowledging that the virus will likely spread to all countries in the world.

The objectives of Corona Virus Net are to be the public and professional information resource for coronaviruses and to serve as a network in the exchange of information and news related to coronaviruses. What do you know about the novel Coronavirus that is causing a health emergency?

• New York City ends its coronavirus alert system as cases hit high levels. - The New York Times
  Fri, 01 Jul 2022 09:10 GMT
• Coronavirus FAQ: Can I get COVID outdoors? (With printable poster on how to cut risks) - WJCT NEWS
  Fri, 01 Jul 2022 20:58 GMT
• Florida's coronavirus deaths rise 795 in two weeks vs. 506 14 days ago - WFLX Fox 29
  Fri, 01 Jul 2022 23:11 GMT
• Governor Lamont Provides Update on Connecticut's Coronavirus Response Efforts - CT.gov
  Thu, 30 Jun 2022 18:52 GMT
• Coronavirus Update: July 1, 2022 - News - Illinois State - Illinois State University News
  Fri, 01 Jul 2022 16:36 GMT
• Outbreak Brief 127: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC - africacdc.org
  Sat, 02 Jul 2022 12:01 GMT
• Illinois Coronavirus Updates: CDC County Maps Updated Ahead of Holiday Weekend - NBC Chicago
  Fri, 01 Jul 2022 18:31 GMT
• California coronavirus updates: July 2022 - capradio.org - Capital Public Radio News
  Fri, 01 Jul 2022 20:46 GMT
• Coronavirus in Illinois: 28K New Cases, 74 Deaths in Last Week as Chicago Moves Back to High Level - NBC Chicago
  Fri, 01 Jul 2022 23:56 GMT
• Coronavirus cases on the rise locally and statewide - The Sun Chronicle
  Sat, 02 Jul 2022 02:15 GMT
• Coronavirus (COVID-19) Update: FDA Recommends Inclusion of Omicron BA.4/5 Component for COVID-19 Vaccine Booster Doses | FDA - FDA.gov
  Thu, 30 Jun 2022 14:00 GMT
• The Inescapable Coronavirus: PCT Days 47-50 - The Trek
  Sat, 02 Jul 2022 05:28 GMT
• UVA COVID-19 Model Weekly Update - Coronavirus - Virginia Department of Health
  Fri, 01 Jul 2022 17:32 GMT
• D.C. ends coronavirus contact tracing effort, laying off 131 workers - The Washington Post
  Thu, 30 Jun 2022 23:46 GMT
• Bad news for Paxlovid? Coronavirus can find multiple ways to evade COVID-19 drug - Science
  Wed, 29 Jun 2022 21:47 GMT

• PRO/AH/EDR> COVID-19 update (323): Pfizer vaccine in children, vaccine diplomacy, WHO
  Mon, 20 Sep 2021 21:44:10 -0400
  COVID-19 -- Worldwide/Unknown
  A lower dose of the Pfizer-BioNTech coronavirus vaccine -- one-3rd the amount given to adults and teens -- is safe and triggered a robust immune response in children as young as 5 years old, the drug companies announced in a news release Monday morning.
  The finding, eagerly anticipated by many parents and pediatricians, is a crucial step toward the 2-shot coronavirus vaccine regimen becoming available for younger school-aged children, perhaps close to Halloween.
  The companies still must

• Anti-SARS-CoV-2 IgM/IgG antibodies detection using a patch sensor containing porous microneedles and a paper-based immunoassay Fri, 01 Jul 2022 06:00:00 -0400
  Infectious diseases are among the leading causes of mortality worldwide. A new coronavirus named severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) was identified in Wuhan, China in 2019, and the World Health Organization (WHO) declared its outbreak, coronavirus disease 2019 (COVID-19), as a global pandemic in 2020. COVID-19 can spread quickly from person to person. One of the most challenging issues is to identify the infected individuals and prevent potential spread of SARS-CoV-2....
• Assessing coherence through linguistic connectives: Analysis of speech in patients with schizophrenia-spectrum disorders Fri, 01 Jul 2022 06:00:00 -0400
  BACKGROUND: Incoherent speech is a core diagnostic symptom of schizophrenia-spectrum disorders (SSD) that can be studied using semantic space models. Since linguistic connectives signal relations between words, they and their surrounding words might represent linguistic loci to detect unusual coherence in speech. Therefore, we investigated whether connectives' measures are useful to assess incoherent speech in SSD.
• chromMAGMA: regulatory element-centric interrogation of risk variants Fri, 01 Jul 2022 06:00:00 -0400
  Candidate causal risk variants from genome-wide association studies reside almost exclusively in noncoding regions of the genome and innovative approaches are necessary to understand their biological function. Multi-marker analysis of genomic annotation (MAGMA) is a widely used program that nominates candidate risk genes by mapping single-nucleotide polymorphism summary statistics from genome-wide association studies to gene bodies. We augmented MAGMA to create chromatin-MAGMA (chromMAGMA), a...
• Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5 Fri, 01 Jul 2022 06:00:00 -0400
  No abstract
• Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis Fri, 01 Jul 2022 06:00:00 -0400
  CONCLUSIONS: LHQW was more suitable for treating COVID-19 patients with obvious expectoration, shortness of breath and muscle soreness. LHQW had advantages in treating COVID-19 with no obvious exacerbation. (PROSPERO No. CRD42021235937).
• Continuous development of the semantic search engine preVIEW: from COVID-19 to long COVID Fri, 01 Jul 2022 06:00:00 -0400
  preVIEW is a freely available semantic search engine for Coronavirus disease (COVID-19)-related preprint publications. Currently, it contains >43 800 documents indexed with >4000 semantic concepts, annotated automatically. During the last 2 years, the dynamic situation of the corona crisis has demanded dynamic development. Whereas new semantic concepts have been added over time-such as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of interest-the service has been also...
• CTPA imaging findings, beyond pulmonary embolism, in patients with Severe Acute Respiratory Syndrome Corona Virus-2 infection and their relation to clinical outcome - a single center experience Fri, 01 Jul 2022 06:00:00 -0400
  CONCLUSIONS: Our study showed that right heart strain as depicted by a RV/LV diameter>1, higher subcutaneous fat density and higher LDH values are independently associated with an increased 28-day mortality in our SARS-COV2 patient group.
• Versatile Protein Coronation Approach with Multiple Depleted Serum for Creating Biocompatible, Precision Nanomedicine Fri, 01 Jul 2022 06:00:00 -0400
  The protein corona effect has long been treated as the evil source behind delivery efficacy issues. In this study, this concept is challenged by showcasing that the protein corona can serve as a versatile functionalization approach to improve the delivery efficacy or mitigate nanocytotoxicity. To this end, the depleted serum is introduced to create nanomaterials carrying functionally distinct protein corona, referred to as PCylated nanomaterials. It is confirmed that the passivation with...
• Perioperative Management for Functional Ganglioneuroma in a 2-Year-Old Child with Multiple Congenital Defects and COVID-19: A Case Report Fri, 01 Jul 2022 06:00:00 -0400
  Unlike neuroblastoma, ganglioneuroma is a rare entity in children younger than 7 years of age. Further, these tumors are mostly inactive endocrinologically with the symptoms of abdominal pain or palpable mass. Unfortunately, when functional, they mimic or occasionally coexist with pheochromocytoma. While perioperative management of pheochromocytoma has evolved, very little is known regarding the periopera- tive management of functioning ganglioneuroma. Hormone secretion due to surgical...
• Hypoallergenic unicompartmental knee arthroplasty and return to sport: comparison between Oxidized Zirconium and Titanium Niobium Nitride Fri, 01 Jul 2022 06:00:00 -0400
  CONCLUSIONS: Both TiNbN and Oxinium UKA procedures enabled patients to return to an acceptable level of sports activity with excellent radiographic outcomes after the final follow up regardless of the age, gender, BMI, and bearing type.